(603087)"Gan & Lee Pharmaceuticals"Report for Q3 2026
Filed with SSE · Stock code 603087 · · 12 pages · Chinese
Gan & Lee Pharmaceuticals Co., Ltd. on 6ix
Earlier from Gan & Lee Pharmaceuticals
- (603087)"Gan & Lee Pharmaceuticals"Announcement on Acquisition of Pharmaceutical Registration Approval for Insulin Glargine Injection (Cartridge) in El Salvador
- (603087)"Gan & Lee Pharmaceuticals"Announcement on Completion of First Subject Dosing in the Phase I Clinical Trial of GLR1075 Injection
- (603087)"Gan & Lee Pharmaceuticals"Announcement on Acquisition of Pharmaceutical Registration Approval for Insulin Glargine Injection (Pre-filled Pen) in El Salvador
- (603087)"Gan & Lee Pharmaceuticals"Announcement on Obtaining the Ethiopian Drug Registration Approval for Insulin Aspart Injection
- "Gan & Lee Pharmaceuticals"Announcement on Obtaining Notice of Approval for Drug Clinical Trials
Follow Gan & Lee Pharmaceuticals into a list and get an email when it puts out news.
Follow Gan & Lee Pharmaceuticals